These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 16131437)
1. Evaluation and management of bleeding during cardiac surgery. Levy JH; Tanaka KA; Steiner ME Curr Hematol Rep; 2005 Sep; 4(5):368-72. PubMed ID: 16131437 [TBL] [Abstract][Full Text] [Related]
2. Mechanisms and attenuation of hemostatic activation during extracorporeal circulation. Despotis GJ; Avidan MS; Hogue CW Ann Thorac Surg; 2001 Nov; 72(5):S1821-31. PubMed ID: 11722116 [TBL] [Abstract][Full Text] [Related]
3. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin. Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201 [TBL] [Abstract][Full Text] [Related]
4. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. ; Ferraris VA; Ferraris SP; Saha SP; Hessel EA; Haan CK; Royston BD; Bridges CR; Higgins RS; Despotis G; Brown JR; ; Spiess BD; Shore-Lesserson L; Stafford-Smith M; Mazer CD; Bennett-Guerrero E; Hill SE; Body S Ann Thorac Surg; 2007 May; 83(5 Suppl):S27-86. PubMed ID: 17462454 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological strategies for blood conservation in cardiac surgery: erythropoietin and antifibrinolytics. Hardy JF Can J Anaesth; 2001 Apr; 48(4 Suppl):S24-31. PubMed ID: 11336434 [TBL] [Abstract][Full Text] [Related]
7. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial. Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838 [TBL] [Abstract][Full Text] [Related]
8. Prohemostatic interventions in liver surgery. Stellingwerff M; Brandsma A; Lisman T; Porte RJ Semin Thromb Hemost; 2012 Apr; 38(3):244-9. PubMed ID: 22510858 [TBL] [Abstract][Full Text] [Related]
9. Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery. Brown JR; Birkmeyer NJ; O'Connor GT Circulation; 2007 Jun; 115(22):2801-13. PubMed ID: 17533182 [TBL] [Abstract][Full Text] [Related]
10. A double-blind, placebo-controlled trial of epsilon-aminocaproic acid for reducing blood loss in coronary artery bypass grafting surgery. Kikura M; Levy JH; Tanaka KA; Ramsay JG J Am Coll Surg; 2006 Feb; 202(2):216-22; quiz A44-5. PubMed ID: 16427545 [TBL] [Abstract][Full Text] [Related]
11. Living without aprotinin: the results of a 5-year blood saving program in cardiac surgery. Ranucci M; Castelvecchio S; Romitti F; Isgrò G; Ballotta A; Conti D Acta Anaesthesiol Scand; 2009 May; 53(5):573-80. PubMed ID: 19173686 [TBL] [Abstract][Full Text] [Related]
12. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery. Karkouti K; Beattie WS; Dattilo KM; McCluskey SA; Ghannam M; Hamdy A; Wijeysundera DN; Fedorko L; Yau TM Transfusion; 2006 Mar; 46(3):327-38. PubMed ID: 16533273 [TBL] [Abstract][Full Text] [Related]
13. Aprotinin use in cardiac surgery patients at low risk for requiring blood transfusion. Kristeller JL; Stahl RF; Roslund BP; Roke-Thomas M Pharmacotherapy; 2007 Jul; 27(7):988-94. PubMed ID: 17594204 [TBL] [Abstract][Full Text] [Related]
14. Current antifibrinolytic therapy for coronary artery revascularization. Trudell J; McMurdy N AANA J; 2008 Apr; 76(2):121-4. PubMed ID: 18478817 [TBL] [Abstract][Full Text] [Related]
15. Prohemostatic agents to prevent perioperative blood loss. Levy JH; Tanaka KA Semin Thromb Hemost; 2008 Jul; 34(5):439-44. PubMed ID: 18956283 [TBL] [Abstract][Full Text] [Related]
16. Transfusion practice in coronary artery bypass surgery in Denmark: a multicenter audit. Andreasen JJ; Westen M; Pallesen PA; Jensen S; Gorst-Rasmussen A; Johnsen SP Interact Cardiovasc Thorac Surg; 2007 Oct; 6(5):623-7. PubMed ID: 17670734 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study. Elwatidy S; Jamjoom Z; Elgamal E; Zakaria A; Turkistani A; El-Dawlatly A Spine (Phila Pa 1976); 2008 Nov; 33(24):2577-80. PubMed ID: 19011538 [TBL] [Abstract][Full Text] [Related]
18. Myocardial injury in cardiac surgery: the role of transfusion. Shore-Lesserson L J Cardiothorac Vasc Anesth; 2000 Jun; 14(3 Suppl 1):11-4; discussion 37-8. PubMed ID: 10890469 [TBL] [Abstract][Full Text] [Related]
19. The impact of aprotinin on blood loss and blood transfusion in off-pump coronary artery bypass grafting. Bittner HB; Lemke J; Lange M; Rastan A; Mohr FW Ann Thorac Surg; 2008 May; 85(5):1662-8. PubMed ID: 18442562 [TBL] [Abstract][Full Text] [Related]
20. [Prophylaxis of blood loss and allogenic blood transfusion with fibrinolysis inhibitors produced in Russian Federation in patients undergoing cardiac surgery]. Bitkova EE; Timerbayev VH; Hvatov VB; Zvereva NY; Chumakov MV; Shumckii KY Anesteziol Reanimatol; 2014; (2):59-64. PubMed ID: 25055497 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]